# The 4100 Group

> The 4100 Group is a VC fund in Lansing backing Health Care, Medical and Hospital. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Lansing, United States
- Total investments: 3
- Last investment: Jan 2022
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/the-4100-group-inc/
- Website: https://www.the4100group.com

The 4100 Group is a VC fund in Lansing focused on Health Care and Medical. The 4100 Group offers investment and wealth management services. The 4100 Group is a joint venture operated by Delta Dental of Michigan and Delta Dental of Ohio.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 67% |
| Medical | 1 | 33% |
| Hospital | 1 | 33% |
| Real Time | 1 | 33% |
| Elder Care | 1 | 33% |

10 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 1 | 33% |
| Series C | 1 | 33% |
| Funding Round | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| VyncaCare | VyncaCare provides palliative care, advanced care planning, and enhanced care management services. | $30M |  | Jan 07, 2022 |  |
| VyncaCare | VyncaCare provides palliative care, advanced care planning, and enhanced care management services. | $30M | Series C | Jan 07, 2022 |  |
| Clarapath | Clarapath is a medical robotics company automating the laboratory. The company's first product is focused on fully automating the microtomy station in pathology. Their vision is to innovate, standardize, and digitally transform anatomic pathology through higher-quality lab medicine, more robust safety standards, and increased lab throughputwhile lowering laboratory costs and labor-related delays.Their next-generation laboratory at the NY Genome Center together with our large-scale image repository and analysis platform are designed to handle the entire “tissue to bits” pipeline for special research projects as well as larger-scale clinical needs. Clarapath works closely with both research and clinical customers to produce faster, more accurate results. | $16M | Series B | Nov 17, 2021 |  |

3 of 3 investments shown.

## Co-investors
- [Questa Capital Management](https://shizune.co/investors/profile/questa-capital-management) — VC Fund, 3 deals together
- [First Trust Capital Partners](https://shizune.co/investors/profile/first-trust-capital-partners) — VC Fund, 2 deals together
- [Generator Ventures](https://shizune.co/investors/profile/generator-ventures) — VC Fund, 2 deals together
- [Northwell Ventures](https://shizune.co/investors/profile/northwell-ventures) — VC Fund, 2 deals together
- [OCA Ventures](https://shizune.co/investors/profile/oca-ventures) — VC Fund, 2 deals together
- [Epiphron Capital](https://shizune.co/investors/profile/epiphron-capital) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does The 4100 Group invest in?

The 4100 Group invests primarily in Health Care, Medical and Hospital startups, most often at Series B and Series C stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did The 4100 Group last invest?

The most recent investment recorded for The 4100 Group closed in Jan 2022. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co